Dr. Nader Sadeghi
- Professor and Chair, Department of Otolaryngology - Head and Neck Surgery 看片视频 University,聽
- Professor, Department of Oncology, 看片视频聽
- Director of 看片视频 Head and Neck Cancer Program聽
MD
Currently supervising students
Development of novel therapeutic strategies for oral and throat cancer聽
- Transoral Robotic Surgery聽
- Transoral Laser Microsurgery聽
- Head and Neck Oncology聽
- Salivary gland surgery聽
- Head and Neck Endocrine Surgery聽
Neoadjuvant Chemotherapy and Transoral Robotic Surgery for oropharyngeal cancer (NECTORS trial), Robotic surgery in head and neck cancer, cancer biology, human papilloma virus (HPV) and head and neck cancer, liquid biopsy, quality of life and outcomes in head and neck cancer, clinical trials, tumor immune micro-environment聽
Dr. Sadeghi presently serves as the Chairman in the Department of Otolaryngology - Head and Neck Surgery at 看片视频.聽 He is also the Chief of the Department of Otolaryngology - Head and Neck Surgery at the MUHC, and Director of 看片视频 Head and Neck Cancer Program.聽
Dr. Sadeghi graduated from 看片视频 Medicine in 1991.聽 He completed his residency at 看片视频 followed by a research fellowship.聽 He then completed a fellowship training in Head and Neck Oncology Surgery at Rush-Presbyterian-St. Luke's Medical Center in Chicago, IL.聽 Following his early career at 看片视频, he moved to the George Washington University in Washington, DC, where he served as Professor of Surgery and Director of Head and Neck Surgery.聽 In 2017, he returned to 看片视频 to lead the department.聽
Dr.Sadeghi鈥檚 research focuses on head and neck cancer and in particular on development of novel therapeutic strategies for oral and throat cancer. I focus on harnessing advances in systemic therapies and minimally invasive robotic surgery to develop novel combinations allowing effective cancer control and minimizing chronic therapy-related toxicity. Through adaptive clinical trials starting with systemic therapy, I am investigating a personalized adaptive approach for surgical treatment of oral and throat cancer. I am investigating molecular determinants of cancer response to chemotherapy to help design personalized treatment with a focus on cancer cure while preserving quality of life and functional outcome after cancer treatment.聽
